Man Group PLC Cara Therapeutics, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $308,623 - $573,335	41,426 New	41,426 $378,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $108,346 - $137,885	-10,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $130,691 - $197,726	10,900 New	10,900 $133,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $171,536 - $323,369	-13,778 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $242,079 - $329,983	13,778 New	13,778 $330,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.